Collects data from heart failure patients during right heart catheterization
Gathers data to develop a non-invasive device estimating heart pressures in people with heart failure.
Plain-language title generated from the registry record
Registry title: A Multi-site, Prospective, Non-interventional, Observational Data Collection Study in Patients Undergoing a Right Heart Catheterization
Key facts
- Where
- Lund, SwedenSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who are referred for a right heart catheterization to measure pressures inside the heart. Heart failure or pulmonary hypertension is the focus.
- Age
- 18 years or older
- Sex
- All sexes can join.
Main reasons for not taking part
- Anyone whose joining is not in their own interest or not in the interest of running the study properly (decided by the study team)
Read by machine on 9 November 2026.
Where in Sweden
- Skåne University Hospital LundLund, SwedenTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Acorai AB
- Trial code
- NCT07010562
- Record updated
- 13 October 2026
- Original description
Acorai is developing a non-invasive monitoring system for the estimation of intracardiac hemodynamic parameters in patients with suspected or confirmed heart failure, and/or pulmonary hypertension, who require hemodynamic assessment. The device will be intended as a companion test or clinical decision support tool to be used and interpreted by qualified healthcare professionals to aid standard-of-care clinical assessment in identifying hemodynamic congestion and supporting personalized treatment of heart failure and pulmonary congestion.Read full original descriptionShow less
A Multi-site, Prospective, Non-interventional, Observational Data Collection Study in Patients Undergoing a Right Heart Catheterization
Acorai is developing a non-invasive monitoring system for the estimation of intracardiac hemodynamic parameters in patients with suspected or confirmed heart failure, and/or pulmonary hypertension, who require hemodynamic assessment. The device will be intended as a companion test or clinical decision support tool to be used and interpreted by qualified healthcare professionals to aid standard-of-care clinical assessment in identifying hemodynamic congestion and supporting personalized treatment of heart failure and pulmonary congestion.
This study is part of the development of a non-invasive monitoring system for the estimation of intracardiac hemodynamic parameters. It will be conducted to collect the data needed to train the machine learning models retrospectively.
Inclusion: Subject is at least 18 years of age at the time of screening; Subject is willing and physically able to comply with the specified evaluations as per the protocol; Subject is referred for invasive hemodynamic assessment with right heart catheterization; Subject has provided written informed consent using the approved consent form.
Exclusion: Discretionary exclusion when the inclusion of a potential subject is not in their best interest or not in the interest of compliant performance of the study.